4 Results for "

TRKC-G623R

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "TRKC-G623R" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-143561
CAS No.: 2762200-57-5
Target:  

Trk Receptor

Research Areas:  

Cancer

Trk-IN-8 is a potent TRK inhibitor with IC50s of 0.42, 0.89 and 1.5 nM for TRKAa, TRKA(G595R) and TRKC(G623R), respectively (WO2021115401A1, compound 3) .
loading...
    loading...
Cat. No.: HY-144069
CAS No.: 2763637-66-5
Target:  

Trk Receptor Apoptosis

Research Areas:  

Cancer

Pan-Trk-IN-3 (Compound 11g) is a potent inhibitor of pan-Trk and their drug-resistant mutants with IC50 values of 2, 3, 2, 21, 26, 5, 7 and 6 nM against TrkA, TrkB, TrkC, TrkA G595R, TrkA G667C, TrkA G667S, TrkA F589L and TrkC G623R, respectively. Pan-Trk-IN-3 displays excellent antitumor activity and induces apoptosis .
loading...
    loading...
Cat. No.: HY-146755
CAS No.: 2846435-83-2
Target:  

Trk Receptor

Research Areas:  

Cancer

TIY-7 is a selective and orally active tropomyosin receptor kinase (TRK) inhibitor. TIY-7 shows enzyme inhibitory activity with IC50s of 2.9, 1.1, 0.7, 0.8, 0.8, 0.2 nM for TRKA, TRKA G595R, TRKA G667C, TRKA F589L, TRKC G623R, TRKC G696A, respectively. TIY-7 shows anti-tumor potency in mouse xenograft model .
loading...
    loading...
Cat. No.: HY-181780
CAS No.: 2489327-91-3
Target:  

Trk Receptor

Research Areas:  

Cancer

TRK-IN-34 is an orally active TRKand TRKC mutant kinase inhibitor, with IC50 values of 0.75 nM and 0.96 nM against TRKA G595R and TRKA G667C, respectively. TRK-IN-34 inhibits the kinase activities of TRKA G595R and TRKA G667C at the functional level. TRK-IN-34 inhibits the proliferation of TRKA-transfected cells, exerts tumor growth-inhibitory effects and achieves partial tumor regression in xenograft models. TRK-IN-34 can be used to study TRK inhibitor-resistant cancers driven by the TRKA G667C mutation .
loading...
    loading...